insights_auto
Why is EDIT up 3,97%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
2,62 $
arrow_upward
+3,97%(+0,100) 1D
2,58 $
arrow_downward
-1,53% (-0,040)todayPre-market
Closed: 2 հոկ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,57 $
High
2,63 $
Low
2,51 $
Mkt. cap
402,38 մլն
Avg. vol.
2,95 մլն
Volume
0,00
52-wk high
4,54 $
52-wk low
1,66 $
EPS
-0,74 $
Beta
2,00
Shares outstanding
153,58 մլն
No. of employees
87
Open
2,57 $
High
2,63 $
Low
2,51 $
Mkt. cap
402,38 մլն
Avg. vol.
2,95 մլն
Volume
0,00
52-wk high
4,54 $
52-wk low
1,66 $
EPS
-0,74 $
Beta
2,00
Shares outstanding
153,58 մլն
No. of employees
87
News stories
From web sources and news partners
Reuters
·
11 րոպե առաջ
Panmure Liberum forecasts S&P 500 falling to 5,000, warns bull run nearing end
Trefis
·
59 րոպե առաջ
S&P 500 Stocks At 52-Week Lows: Friday’s Full List
Investing.com
·
48 րոպե առաջ
S&P 500: 7,900 Still in Sight, but Rising Yields Raise the Risk
Yahoo Finance
·
2 ժամ առաջ
Stock Market: Will S&P 500 Open Up or Down Today?
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc